Pharmacy Leaflets Become Focus For Patient Safety; IoM, FDA Finalize Standards
This article was originally published in The Tan Sheet
Executive Summary
Producers of consumer medication information leaflets are hoping that FDA provides them with more time to come into compliance with standards for usefulness, even as an Institute of Medicine report is emphasizing the need for quality in the materials
You may also be interested in...
FDA Seeks To Prevent Drug Name Confusion, While USP Develops Treatment
The U.S. Pharmacopeia's new searchable drug database is designed to help consumers and caregivers avoid errors due to look-alike/sound-alike product names
FDA Seeks To Prevent Drug Name Confusion, While USP Develops Treatment
The U.S. Pharmacopeia's new searchable drug database is designed to help consumers and caregivers avoid errors due to look-alike/sound-alike product names
FDA Seeks To Prevent Drug Name Confusion, While USP Develops Treatment
The U.S. Pharmacopeia's new searchable drug database is designed to help consumers and caregivers avoid errors due to look-alike/sound-alike product names